Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short versus long methotrexate-based chemotherapy for low-risk gestational trophoblastic neoplasia
ISRCTN74959523Phase 3Completed
- Sponsor
- National Academy of Medical Sciences (India)
- Start
- Jan 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of methotrexate, actinomycin D and folinic acid in trophoblastic tumour and choriocarcinoma (2 arms), sponsored by National Academy of Medical Sciences (India). Primary endpoint: Time to achieve normal serum beta-hCG. Started Jan 2018; status: completed.
02
Drugs
methotrexateactinomycin Dfolinic acid
03
Conditions
trophoblastic tumourchoriocarcinoma
Beyond the preview
Go deeper on ISRCTN74959523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN74959523.